Several pharmaceutical companies have recently said they’ll delay some of their price increases, under pressure from the Trump administration. But hospitals have made no such concessions, even though they make up a much larger share of total health care spending.
Pfizer, Novartis, Merck and other drug makers have said they will delay, freeze or roll back price increases on some of their medicines. Experts largely dismissed those pledges as political bandages with little real effect on patients’ pocketbooks.
Digital health is one of the hottest spaces for investment, with companies raising $1.6 billion in venture capital in the first quarter of 2018.
Digital health companies are getting really good at screening populations of people for health problems before they develop into serious medical issues, but they struggle to get patients into their doctor.
Medical experts say that digital health can’t do much for users that are already sick, or at high risk of a serious medical condition.
The biggest threats to our health care is not the cost of prescription drugs.
The health insurance industry is tracking your race, education level, TV habits, marital status, net worth. They’re collecting what you post on social media, whether you’re behind on your bills, what you order online. Then they feed this information into complicated computer algorithms that spit out predictions about how much your health care could cost them.
Medical experts say that digital health can’t do much for users that are already sick, or at high risk of a serious medical condition. Many of these companies won’t diagnose disease for regulatory reasons, even if they’re picking up strong signals through sensors and algorithms, so instead they’ll suggest that a user see their doctor.